Search results for " biopharma"
Article
Reimagining Affordable Biosimilars
More than 300 active biopharmaceutical product licenses in the market today bear witness to increasing interest in targeted treatments. With an anticipated valuation of over $200 billion by 2022, this…
Article
Testa Challenge 2020 Attracts Leading International Bioprocessing Innovators
Read more here >>
Six bioprocessing innovators have successfully completed the inaugural Testa Challenge 2020. Held over an intensive week in the Testa Center located at Cytiva´s Uppsala…
Article
Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.
On Sept. 13, 2020, Cytiva, announced that it is investing $500 million o…
Article
Cytiva Introduces the Xcellerex Automated Perfusion System
The APS system comes equipped with filter switching, liquid management, and cell bleed to reduce risk of human error and increase process robustness.
Cytiva announced on Sept. 16, 2020 that it i…
Article
Connected, Automated Downstream Process for mAb Screening and Evaluation
Click here to read more >>
A pre-clinical lab is often faced with the need to constantly evaluate possible ways of increasing capacity and throughput. This study was done to show both proof of p…
Article
DiPIA online
Join on-demand presentations >>
Biacore surface plasmon resonance application specialists are eager to share their experience in assay design, validation, and data evaluation.
Resource
DiPIA online
Biacore SPR application specialists are eager to share their experience in assay design, validation, data evaluation.
Join on-demand presentations
Article
Purifying Samples for Cryo-EM Preps
Click here to register for the webinar >>
Technical improvements in cryogenic electron microscopy (cryo-EM) have triggered a revolution in structural biology and made single-particle cryo-EM …
Article
Strategizing for Rapid Changeovers in Biologics Manufacturing
Equipment selection matters too
In general, the equipment developed for the biopharmaceutical industry includes built-in functionality—both hardware and software—to make changeovers easier, accord…
Article
Oligonucleotide Therapeutics Heading for Tons of Quantity in Annual Supply Need
Click here to read the full article >>
Solid-phase flow through technology poised to annually produce metric tons (1000 kg) provides the oligonucleotide therapeutic industry efficient synthesis t…